Skip to main content
Signal8

Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc.

OTC:EVFMHealthcare
AH+0.00%$0.0043
Close$0.0043-28.93%
Mkt Cap$570K
EV-
Float132.53M
O/S132.53M
VOL2.7M sh
$ Vol$13K
RVOL24.51×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Evofem Biosciences, Inc. logoOTC:EVFMAH$0.0043+0.00%
Short interest (FINRA)
0.0%
Oct 30 (18d)

Float 132.53M · Signal8 dilution snapshot · Nov 13, 2026

11.4K
Oct 30 (18d)prev 4.8K▲ 134.6%
1.00
Oct 30 (18d)prev 1.00– 0.0%
Borrow (IBKR)

The cost to borrow EVFM shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
1.0%
Nov 13 (4d)prev 5.5%▼ 4.5 pts

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

11.6K
Jun 17 (153d)prev 21.0K▼ 44.7%
Price, short interest & fails to deliver
Short interest · today's share basis23 settlements
Fails to deliver5 settlement dates
Latest short interest settlements (today's share basis)
DateShares short
Oct 30, 202611.4K sh
Oct 15, 20264.8K sh
Sep 30, 202610.0K sh
Sep 15, 202611.2K sh
Aug 31, 202629.5K sh
Latest fails to deliver
DateShares failed
Jun 17, 202611.6K sh
Jun 16, 202621.0K sh
Jun 4, 202610.8K sh
Jun 3, 2026837 sh
Jun 2, 2026837 sh

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume
Nov 13
Latest sessions
DateReported short
Nov 13, 20261.0%
Nov 12, 20265.5%
Nov 11, 202665.3%
Nov 10, 20260.7%
Nov 9, 202636.6%
87-session median 23.6%mean 30.6%range 0.0–99.9%

130 calendar days requested; 88 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.

Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.

Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for EVFM: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually

As of the Oct 30, 2026 FINRA settlement, 11,365 EVFM shares were sold short (0.01% of a 132.53M-share float, 1.00 days to cover).